# Aurobindo Pharma Ltd - Inspection Records

Source: https://www.globalkeysolutions.net/companies/aurobindo-pharma-ltd/169fdedf-28b5-446b-84f4-65ca9bc54a1a

> Inspection records and compliance data for Aurobindo Pharma Ltd in Medchal, None. Access full analysis and detailed observations.

---

## Details

- Name: Aurobindo Pharma Ltd
- FEI Number: 3004021229
- City: Medchal
- State: None
- Country Name: India
- Address Line 1: Unit 3, Survey 313 & 314, Bachupally, Medchal-Malkajgiri District
- Zip Code: None
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE

## Related Documents

- [483 - Aurobindo Pharma Ltd - 2023-07-21](https://www.globalkeysolutions.net/records/483/aurobindo-pharma-ltd/33feb8af-e76c-4b11-bcf0-12ef27f2e475) — source: FDA, date: July 21, 2023
- [FDA Inspection 1210950 - Aurobindo Pharma Ltd - 2023-07-21](https://www.globalkeysolutions.net/records/fda_inspections/aurobindo-pharma-ltd/456ed1f7-cbc3-4ed8-a484-85c4b018e2fa) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 21, 2023
- [FDA Inspection 1155879 - Aurobindo Pharma Ltd - 2019-07-05](https://www.globalkeysolutions.net/records/fda_inspections/aurobindo-pharma-ltd/e8cd4524-33fa-45ed-b5a3-3ee40152e6ac) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 5, 2019
- [483 - Aurobindo Pharma Ltd - 2019-05-24](https://www.globalkeysolutions.net/records/483/aurobindo-pharma-ltd/ed01b8a9-88db-401b-b91c-4b4446c83461) — source: FDA, date: May 24, 2019
- [FDA Inspection 1090627 - Aurobindo Pharma Ltd - 2019-05-24](https://www.globalkeysolutions.net/records/fda_inspections/aurobindo-pharma-ltd/e3cd1f8d-155d-4a10-b7f7-2443f3cc028c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 24, 2019
- [483 - Aurobindo Pharma Ltd - 2018-12-14](https://www.globalkeysolutions.net/records/483/aurobindo-pharma-ltd/f2b68946-1a20-4c83-b130-07cf6893348c) — source: FDA, date: December 14, 2018
- [FDA Inspection 1061698 - Aurobindo Pharma Ltd - 2018-08-10](https://www.globalkeysolutions.net/records/fda_inspections/aurobindo-pharma-ltd/0cdaca41-dc53-4b79-8067-cf57d8aaed89) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 10, 2018
- [483 - Aurobindo Pharma Ltd - 2017-04-18](https://www.globalkeysolutions.net/records/483/aurobindo-pharma-ltd/96bc5d60-2e90-4ff4-a4e9-85bdabf692db) — source: FDA, date: April 18, 2017
- [FDA Inspection 1010385 - Aurobindo Pharma Ltd - 2017-04-18](https://www.globalkeysolutions.net/records/fda_inspections/aurobindo-pharma-ltd/83bc7209-2966-4c8d-84a1-86ccb14266cc) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 18, 2017
- [FDA Inspection 960797 - Aurobindo Pharma Ltd - 2016-01-29](https://www.globalkeysolutions.net/records/fda_inspections/aurobindo-pharma-ltd/fb599332-3132-4215-8ce4-8accc505ba0c) — classification: No Action Indicated (NAI), source: FDA, date: January 29, 2016
- [FDA Inspection 940768 - Aurobindo Pharma Ltd - 2015-06-26](https://www.globalkeysolutions.net/records/fda_inspections/aurobindo-pharma-ltd/8193b907-babd-4e2b-a9f2-85004d6143d1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 26, 2015
- [FDA Inspection 774770 - Aurobindo Pharma Ltd - 2012-03-02](https://www.globalkeysolutions.net/records/fda_inspections/aurobindo-pharma-ltd/33889aef-b20a-4a1c-ba27-7495bfc2e3a5) — classification: No Action Indicated (NAI), source: FDA, date: March 2, 2012
- [FDA Inspection 750125 - Aurobindo Pharma Ltd - 2011-09-08](https://www.globalkeysolutions.net/records/fda_inspections/aurobindo-pharma-ltd/80ca2962-91b2-4df1-a774-6a6b76e7c6b3) — classification: No Action Indicated (NAI), source: FDA, date: September 8, 2011
- [FDA Inspection 750125 - Aurobindo Pharma Ltd - 2011-09-08](https://www.globalkeysolutions.net/records/fda_inspections/aurobindo-pharma-ltd/f4e0027a-3483-4796-a388-ea3abed4f552) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 8, 2011

## Related Companies

- [Iso-Tex Diagnostics, Inc.](https://www.globalkeysolutions.net/companies/iso-tex-diagnostics-inc/59c59676-32cc-4749-b95d-3bdc31559b58)
- [Zydus Lifesciences Limited](https://www.globalkeysolutions.net/companies/zydus-lifesciences-limited/4904f62e-dd42-4ea9-b381-cb6e5d44558d)
- [AIAC International Pharma, LLC](https://www.globalkeysolutions.net/companies/aiac-international-pharma-llc/f2a0eb8d-93c0-4b7e-a46c-72f483b241c3)
- [Apotex Research Private Limited](https://www.globalkeysolutions.net/companies/apotex-research-private-limited/074db0b0-4f5f-4ee7-90e9-1c661c86f90c)
- [MSD International GmbH (Singapore Branch)](https://www.globalkeysolutions.net/companies/msd-international-gmbh-singapore-branch/acbc6490-ca0c-4304-8210-a35e4c4cbd79)
- [Fresenius Kabi USA LLC](https://www.globalkeysolutions.net/companies/fresenius-kabi-usa-llc/f694c817-29ea-47cf-b819-8cf11fbfc4da)
- [Vetter Pharma Fertigung GmbH & Co. KG](https://www.globalkeysolutions.net/companies/vetter-pharma-fertigung-gmbh-co-kg/6b51041e-37a7-4672-a7e2-c3c871d6231b)
- [Seqirus Pty Ltd](https://www.globalkeysolutions.net/companies/seqirus-pty-ltd/673f8bd1-d8ea-4125-a3cf-a83827b17359)
- [Agnitio Inc](https://www.globalkeysolutions.net/companies/agnitio-inc/6bcd09b9-e002-45bf-805c-0e4474b1bdfb)
- [LFB USA, Inc.](https://www.globalkeysolutions.net/companies/lfb-usa-inc/0ce33194-ad37-4a33-ac26-fb8a40ba3c7c)

## Related Officers

- [Cheryl A. Clausen](https://www.globalkeysolutions.net/people/cheryl-a-clausen/2306b2bc-8f01-4f77-ba2d-1a3186d6f6fc)
- [Angela Glenn](https://www.globalkeysolutions.net/people/angela-glenn/5ba5e1e2-883b-42c4-aae0-3564820723e8)
- [Jose A. Cruz Gonzalez](https://www.globalkeysolutions.net/people/jose-a-cruz-gonzalez/a005cff1-0a90-4396-82c4-de4b0a579374)
- [Vice President Quality](https://www.globalkeysolutions.net/people/rajesh-kulkarni/e4d8a2aa-4c08-4905-bf8a-bbb14d386fbc)
- [Arsen Karapetyan](https://www.globalkeysolutions.net/people/arsen-karapetyan/4000d909-277b-4533-992f-4e3627c8ce40)